Showing results (1101-1110 of 2,737) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|July 25, 2020
Pharmacogenomics of methadone: a narrative review of the literatureSenthil Packiasabapathy, Blessed W Aruldhas, Nicole Horn, et al.
Pharmacogenomics|August 22, 2020
Association between genetic polymorphism and antidepressants in major depression: a network meta-analysisDan Du, Qiong Tang, Qiong Han, et al.
Pharmacogenomics|July 9, 2020
PARC report: health outcomes and value of personalized medicine interventions: impact on patient careChristina Mitropoulou, Veronika Litinski, Boyko Kabakchiev, et al.
Pharmacogenomics|March 31, 2023
Effects of MDR1 and OPRM1 genetic polymorphisms on the pharmacodynamics of propofol-remifentanil TIVA in pediatricsYee Liew, Francis R Capule, Raha Abdul Rahman, et al.
Pharmacogenomics|March 31, 2023
Pharmacogenetic interactions of medications administered for weight loss in adults: a systematic review and meta-analysisJoelle BouSaba, Kia Vosoughi, Saam Dilmaghani, et al.
Pharmacogenomics|June 7, 2006
Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipientsChi Yuen Cheung, Robert A M Op den Buijsch, Kim Ming Wong, et al.
Pharmacogenomics|June 7, 2006
Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8Elena García-Martín, Rosa M Pizarro, Carmen Martínez, et al.
Pharmacogenomics|June 7, 2006
EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactionsMariam Molokhia, Paul McKeigue
Pharmacogenomics|March 18, 2009
Update on the pharmacogenetics of the vitamin D receptor and osteoporosisLuigi Gennari, Daniela Merlotti, Vincenzo De Paola, et al.
Pharmacogenomics|March 18, 2009
CYP3A5 and ABCB1 genes and hypertensionMurielle Bochud, Pascal Bovet, Michel Burnier, et al.
Pageof 274